#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13858	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2440	695.2	0	.	n	.	0	C1450T	SNP	1450	1450	C	1852	1852	T	883	T,G	881,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13858	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2440	695.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1586	1586	C	891	C	891	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23350	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4002	726.8	0	.	n	.	0	T695C	SNP	695	695	T	1222	1222	C	850	C,A	845,4	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23350	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4002	726.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1864	1864	A	951	A,C	950,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23350	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4002	726.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2498	2498	C	754	C	754	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23350	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4002	726.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2572	2572	A	723	A,C,T	720,2,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23350	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4002	726.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	3124	3124	C	822	C,A,T	820,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	2112	folP	855	855	100.0	folP.l15.c4.ctg.1	2062	127.4	1	SNP	p	R229S	0	.	.	685	687	CGC	1203	1205	CGC	207;208;208	C,A;G;C	205,2;208;208	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5454	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3833	177.2	1	SNP	p	S91F	0	.	.	271	273	TCC	754	756	TCC	194;196;199	T;C;C	194;196;199	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5454	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3833	177.2	1	SNP	p	D95G	0	.	.	283	285	GAC	766	768	GAC	207;208;206	G;A;C	207;208;206	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5454	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3833	177.2	1	SNP	p	D95N	0	.	.	283	285	GAC	766	768	GAC	207;208;206	G;A;C	207;208;206	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	2002	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1755	142.2	1	SNP	p	G45D	1	.	.	133	135	GAC	699	701	GAC	232;235;235	G;A;C,A	232;235;234,1	mtrR.WHO_L_00489c:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1140	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c30.ctg.1	1384	102.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5252	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3637	180.2	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1949	1951	GCA	235;237;237	G,T;C,A;A	234,1;236,1;237	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5252	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3637	180.2	1	SNP	p	D86N	0	.	.	256	258	GAC	902	904	GAC	218;221;221	G,A;A,C;C	217,1;220,1;221	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5252	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3637	180.2	1	SNP	p	S87W	0	.	.	259	261	AGT	905	907	AGT	218;217;218	A,G;G;T	217,1;217;218	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5252	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3637	180.2	1	SNP	p	S87R	0	.	.	259	261	AGT	905	907	AGT	218;217;218	A,G;G;T	217,1;217;218	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5252	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3637	180.2	1	SNP	p	S87I	0	.	.	259	261	AGT	905	907	AGT	218;217;218	A,G;G;T	217,1;217;218	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5252	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3637	180.2	1	SNP	p	S88P	0	.	.	262	264	TCC	908	910	TCC	220;220;220	T;C;C,A	220;220;219,1	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4296	parE	1986	1986	99.9	parE.l15.c4.ctg.1	2998	178.3	0	.	p	.	0	V89A	NONSYN	265	267	GTC	760	762	GCC	225;225;226	G;C;C	225;225;226	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4296	parE	1986	1986	99.9	parE.l15.c4.ctg.1	2998	178.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1723	1725	GGC	234;235;232	G,T;G;C,G,A	233,1;235;230,1,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.1.001	penA.1.001	1	1	27	3860	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2808	171.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1456	1458	GCA	233;233;232	G;C;A	233;233;232	penA.1.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	3860	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2808	171.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1459	1461	ATC	230;228;227	A;T;C	230;228;227	penA.1.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	3860	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2808	171.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1471	1473	GTG	223;220;224	G,C,T;T;G,T	221,1,1;220;222,2	penA.1.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	3860	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2808	171.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1471	1473	GTG	223;220;224	G,C,T;T;G,T	221,1,1;220;222,2	penA.1.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	3860	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2808	171.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1975	1977	ACC	220;221;222	A;C;C	220;221;222	penA.1.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	3860	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2808	171.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2029	2031	GCG	208;208;212	G,T;C,A;G,C	207,1;207,1;211,1	penA.1.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	3860	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2808	171.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2029	2031	GCG	208;208;212	G,T;C,A;G,C	207,1;207,1;211,1	penA.1.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	3860	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2808	171.1	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2152	2154	GGC	215;216;216	G;G,T;C	215;215,1;216	penA.1.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	3860	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2808	171.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2161	2163	GGC	217;217;215	G;G;C	217;217;215	penA.1.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	3860	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2808	171.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2179	2181	CCG	221;220;219	C;C,A;G	221;219,1;219	penA.1.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5472	ponA	2397	2397	99.96	ponA.l6.c4.ctg.1	3664	186.1	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1999	2001	CTG	204;205;204	C;T;G,T,A	204;205;201,1,1	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2844	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2355	150.6	0	.	p	.	0	S22G	NONSYN	64	66	AGC	644	646	GGC	215;212;216	G,C;G,A;C	214,1;211,1;216	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2844	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2355	150.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	826	826	C	203	C	203	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	2788	porB1a	984	984	99.9	porB1a.l15.c4.ctg.1	2074	167.2	0	.	p	.	0	Y39H	NONSYN	115	117	TAC	585	587	CAC	236;238;235	C;A,C;C,A	236;237,1;234,1	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	9296	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5348	216.7	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2254	2256	CAT	242;241;243	C;A;T,G	242;241;241,2	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	1328	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1475	112.1	1	SNP	p	V57M	0	.	.	169	171	GTG	742	744	GTG	231;228;229	G;T,A;G	231;227,1;229	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
